Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05570292
Other study ID # FMASU MS210/2022
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date October 10, 2022
Est. completion date April 20, 2023

Study information

Verified date May 2023
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

General Anesthesia requires preoperative fasting according to specific instructions. Regarding Fasting Guidelines, The American Society of Anesthesiologists (ASA) recommends patients to fast from fatty food or meat eight hours prior to surgery, non-human milk or light meal for six hours prior, breast milk for four hours prior, and clear liquids including water, pulp-free juice, and tea without milk for two hours prior to the anesthetic. ASA fasting guidelines application represents the primary method to avoid aspiration as it ensures that stomach is empty before induction of anesthesia. These guidelines cannot be applied on all cases as in urgent or emergent situations or in morbidities associated with delayed gastric emptying, like Diabetes mellitus and some neurological disorders (


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date April 20, 2023
Est. primary completion date April 20, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Patients of both sexes - aged between 18-65 years - who are categorized by ASA physical status as I or II - undergoing elective surgeries under general anesthesia Exclusion Criteria: - Patients with known or suspected delayed gastric emptying (e.g. Diabetes mellitus) -psychiatric disorders - hypersensitivity to the study medications - peoples undergoing surgeries that associated with high incidence of Post operative nausea and vomiting (PONV) (e.g. Cholecystectomy, gynecological, ophthalmological, otorhinolaryngological, and laparoscopic surgeries).

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Domperidone
ultrasound guieded assesment of gastric residual volume will be done 2 h after oral injestion of domperidone tablet
Folic acid
ultrasound guieded assesment of gastric residual volume will be done 2 h after oral injestion of folic acid tablet

Locations

Country Name City State
Egypt Ain Shams University hospitals Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary assess the effect of oral Domperidone preoperatively on gastric residual volume by ultrasound for patients undergoing elective surgeries under general anesthesia patients will receive 400 ml of apple juice as a clear fluid, two hours preoperatively, and oral Domperidone tab or placebo tab first 2 hours preoperative
See also
  Status Clinical Trial Phase
Recruiting NCT05888090 - The Effect of Position Given to Preterms After Feeding on Gastric Residual Volume, Abdominal Oxygenation and Fractional Oxygen Extraction N/A
Recruiting NCT05355428 - Reducing Fasting Time for Breast Milk to 3 Hours N/A
Completed NCT04062851 - Routine Versus no Assessment of Gastric Residual Volumes in Preterm Infants N/A
Not yet recruiting NCT03948594 - The Effect of Carbohydrate Loading on Gastric Residual Volume and Hunger Score N/A
Completed NCT03952260 - Feasibility of 1 Hour Clear Fluid Fasting Prior to Paediatric GA N/A
Completed NCT04682691 - Effect of Metoclopramide Versus Erythromycin on on Gastric Residual Volume Phase 4
Completed NCT05106933 - The Effect of Carbohydrate Loading 2 Hours Before Gastroscopy on Gastric Residual Volume and Patient's Well-being Score N/A